Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-26

Clinical Trial Update: Cardiovascular Effects in Psoriasis Patients Treated With Adalimumab. [NA]

View source ↗

Summary

The trial evaluated cardiovascular effects of adalimumab in psoriasis patients; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Psoriasis | NA | Status: COMPLETED | Results posted: 2016-12-26